28.07.2011 • NewsBayerQ2 2011sales and profits

Bayer Reports €747 Million in Q2 Sales

German healthcare and high-tech materials company Bayer said net profit for the second quarter totaled €747 million compared to €530 million in the prior year quarter. Earnings per share were €0.90, higher than €0.64 a year ago.

Core earnings per share for the recent quarter amounted to €1.29 versus €1.16 in the previous year.

Sales of the Bayer Group for the three months increased 0.8% to €9.252 billion from €9.179 billion in the prior year. Adjusted for currency and portfolio effects, sales were up by 5.4%.

"We confirm the full-year sales and earnings forecast that we raised in April," said CEO Marijn Dekkers said.

Bayer said it continues to target a currency- and portfolio-adjusted sales increase of between 5% and 7%, which corresponds to group sales of between €36 billion and €37 billion. Core earnings per share for 2011 are still expected to improve by about 15%, the company said in a statement.

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.